Status:
RECRUITING
Antibacterial Photodynamic Therapy in the Management of Peri-implantitis
Lead Sponsor:
Nilminie Rathnayake
Collaborating Sponsors:
University of Helsinki
Conditions:
Peri-Implantitis
Plaque, Dental
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This early-stage study is designed to determine the efficacy of the Lumoral method in periimplantitis. Improved supragingival plaque control can help to also sustain subgingival plaque management in t...
Detailed Description
Clinical signs of inflammation in peri-implantitis include bleeding on probing, suppuration, increased probing depth, and radiographic signs of bone loss. Currently, the best treatment options for per...
Eligibility Criteria
Inclusion
- PPD ≥6 mm and marginal bone loss \>3 mm
- Dental implants collected and clinically characterized according to Lähteenmäki et al. CEDR-22
- Agreement to participate in the study and to sign a written consent form
- Able to co-operate with the treatment protocol and avoid any other oral hygiene measures outside of the study protocol
Exclusion
- Presence of any physical limitation or restriction that might restrict Lumoral use
- Unwilling to participate in the study
- Pregnancy or lactation
- Active smoking
- Medicated diabetes mellitus (DM)
- Any systemic disease (e.g., wound healing dysfunctions) that could alter the progression of peri-implantitis
- Use of antibiotics and doxycycline, chlorhexidine, and bisphosphonates, within 4 weeks week prior to study participation
- Peri-implant and periodontal treatment within 3 months prior to study participation
- Removable major prosthesis or major orthodontic appliance
Key Trial Info
Start Date :
May 13 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06017817
Start Date
May 13 2024
End Date
December 31 2026
Last Update
October 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Södertandläkarna AB
Stockholm, Sweden, 11622